1. Home
  2. TNXP vs ACNT Comparison

TNXP vs ACNT Comparison

Compare TNXP & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$13.65

Market Cap

172.7M

Sector

Health Care

ML Signal

HOLD

Logo Ascent Industries Co.

ACNT

Ascent Industries Co.

HOLD

Current Price

$13.28

Market Cap

161.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNXP
ACNT
Founded
2007
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
172.7M
161.0M
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
TNXP
ACNT
Price
$13.65
$13.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
419.1K
149.9K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
91.75
106.72
EPS
N/A
0.09
Revenue
$13,107,000.00
N/A
Revenue This Year
$558.11
N/A
Revenue Next Year
$38.29
N/A
P/E Ratio
N/A
$145.56
Revenue Growth
29.85
N/A
52 Week Low
$11.60
$11.62
52 Week High
$69.65
$17.92

Technical Indicators

Market Signals
Indicator
TNXP
ACNT
Relative Strength Index (RSI) 46.22 43.18
Support Level $13.32 $11.91
Resistance Level $20.36 $16.80
Average True Range (ATR) 1.18 0.43
MACD -0.03 0.20
Stochastic Oscillator 37.93 82.35

Price Performance

Historical Comparison
TNXP
ACNT

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

About ACNT Ascent Industries Co.

Ascent Industries Co specializes in development, production, and distribution of specialty chemicals. The company produces specialty ingredients and products for the oil and gas, household, industrial and institutional, personal care, coatings, adhesive, sealants, elastomers, pulp and paper, textile, automotive, agricultural, water, treatment, and construction industries. The products of the company include: Surfactants, Defoamers, Flame Retardants, Emulsifiers, Lubricants, Plasticizers, Straight Esters and Others.

Share on Social Networks: